Metropolitan Life Insurance Company (MetLife)’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,018
| Closed | -$397K | – | 2619 |
|
|
2020
Q4 | $397K | Sell |
3,018
-854
| -22% | -$112K | 0.01% | 1509 |
|
|
2020
Q3 | $196K | Hold |
3,872
| – | – | ﹤0.01% | 1790 |
|
|
2020
Q2 | $185K | Hold |
3,872
| – | – | ﹤0.01% | 1858 |
|
|
2020
Q1 | $190K | Hold |
3,872
| – | – | ﹤0.01% | 1619 |
|
|
2019
Q4 | $222K | Hold |
3,872
| – | – | ﹤0.01% | 1843 |
|
|
2019
Q3 | $139K | Sell |
3,872
-2,242
| -37% | -$80.6K | ﹤0.01% | 2119 |
|
|
2019
Q2 | $190K | Hold |
6,114
| – | – | ﹤0.01% | 1921 |
|
|
2019
Q1 | $143K | Buy |
+6,114
| New | +$143K | ﹤0.01% | 2110 |
|